血型CD36基因在泛癌中的综合分析

doi:10.3969/j.issn.1671-2587.2024.02.015

临床输血与检验 ›› 2024, Vol. 26 ›› Issue (2): 251-261.DOI: 10.3969/j.issn.1671-2587.2024.02.015

血型CD36基因在泛癌中的综合分析

周仁龙¹, 李凌波², 闫岩³, 唐丹丹⁴

¹深圳市龙华区中心医院输血科 518100;
²吉林省健康管理学会、深圳爱康生物科技股份有限公司学术顾问;
³广东新安职业技术学院医药健康学院 518052;
⁴深圳市南山区医疗集团总部 518000

收稿日期:2023-11-28 出版日期:2024-04-20 发布日期:2024-04-23
通讯作者: 唐丹丹,主要从事输血与肿瘤的相关基础研究,（E-mail）1024129289@qq.com。
作者简介:周仁龙,主要从事血型与疾病相关的基础研究,（E-mail）942322151@qq.com。并列第一作者：李凌波,主要从事血液免疫学相关研究,（E-mail）109738086@qq.com。

Comprehensive Analysis of Blood Group Gene CD36 in Pan Cancer

ZHOU Renlong¹, LI Lingbo², YAN Yan³, TANG Dandan⁴

¹Department of Blood Transfusion, Shenzhen Longhua District Central Hospital, Shenzhen 518100;
²Aikang MedTech Co., Ltd;
³Guangdong Xin'an Polytechnic;
⁴Shenzhen Nanshan District Medical Group Headquarters 518000

Received:2023-11-28 Online:2024-04-20 Published:2024-04-23

摘要/Abstract

摘要： 目的通过生物信息学方法研究血型CD36基因在人类恶性肿瘤的表达及其与预后、临床分期和免疫浸润的关系,阐明其对肿瘤的预后评估价值。方法运用UALCAN数据库分析CD36蛋白在肿瘤组织和正常组织间的表达差异;运用GEPIA数据库分析CD36表达与泛癌分期之间的关系;运用SangerBox数据库分析CD36表达与泛癌患者生存预后的关系,分析泛癌中CD36蛋白表达与免疫浸润及TMB、MSI等的相关性,运用String数据库分析与CD36上下游相关的蛋白。结果研究显示CD36基因在9种肿瘤中观察到了显著上调（P<0.05）,18种肿瘤中观察到了显著下调（P<0.05）,CD36表达的高低与不同类型肿瘤患者的分期和预后密切相关,CD36在不同的肿瘤中发挥着不同的作用。CD36基因在39个癌种中表达与免疫浸润显著正相关（P<0.05）,CD36可能在调节肿瘤免疫环境方面起到重要作用。KEGG和GO富集分析结果显示,候选基因主要参与了toll样受体信号通路、NF-κB信号通路和免疫相关通路免疫应答激活信号。结论 CD36基因在不同肿瘤中存在表达差异,CD36基因与多种肿瘤患者的分期和预后密切相关,血型CD36基因有望作为一个重要的肿瘤预后预测基因。

关键词: 血型CD36基因, 泛癌分析, 肿瘤微环境, 免疫浸润

Abstract: Objective The study aimed to elucidate the prognostic value of CD36 in cancer and its relationship with immune infiltration across different cancer types.Bioinformatics methods were employed to study the expression of blood type gene CD36 in human malignant tumors and its relationship with prognosis, clinical staging, and immune infiltration. Methods UALCAN database was used to analyze the difference of CD36 protein expression between tumor tissues and normal tissues. GEPIA database was used to analyze the relationship between CD36 expression and pan-cancer stage. The SangerBox database was used to analyze the relationship between CD36 expression and the survival prognosis of pan-cancer patients, the correlation between CD36 expression and immune infiltration in pan-cancer, the correlation between CD36 expression and TMB,MSI, etc., and the String database was used to analyze the upstream and downstream proteins related to CD36. Results There was significant upregulation of the CD36 gene in 9 types of tumors (P<0.05), while significant downregulation was observed in 18 types of tumors (P<0.05). The expression levels of CD36 were closely associated with the staging and prognosis of different types of cancer patients. CD36 plays different roles in different types of tumors. The expression of CD36 in 39 cancer types was significantly positively correlated with immune infiltration (P<0.05), suggesting its important role in regulating the tumor immune environment. KEGG and GO enrichment analysis showed that candidate genes mainly participate in toll-like receptor signaling pathway, NF-κB signaling pathway, and immune response activation signaling. Conclusion CD36 exhibits expression variations in different tumors, and its expression is closely associated with the staging and prognosis of various cancer patients. Blood type CD36 gene is expected to serve as an important prognostic predictor for tumors.

Key words: Blood type CD36 gene, Pancancer analysis, Tumor microenvironment, Immune infiltration

中图分类号:

R730R457.11

周仁龙, 李凌波, 闫岩, 唐丹丹. 血型CD36基因在泛癌中的综合分析[J]. 临床输血与检验, 2024, 26(2): 251-261.

ZHOU Renlong, LI Lingbo, YAN Yan, TANG Dandan. Comprehensive Analysis of Blood Group Gene CD36 in Pan Cancer[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(2): 251-261.

参考文献

[1] ZHANG Y,LIU Q Q,ZHANG X M,et al.Recent advances in exosome-mediated nucleic acid delivery for cancer therapy[J].J Nanobiotechnology,2022,20(1):279.
[2] TOMEH M A,HADIANAMREI R,ZHAO X B.A review of curcumin and its derivatives as anticancer agents[J].Int J Mol Sci,2019,20(5):1033.
[3] TOBORE T O.On the need for the development of a cancer early detection,diagnostic,prognosis,and treatment response system[J].Future Sci OA,2019,6(2):FSO439.
[4] QIN Y,LIU Y L,XIANG X Y,et al.Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis[J].Mol Cancer,2023,22(1):59.
[5] GUERRERO-RODRÍGUEZ S L,MATA-CRUZ C,PÉREZ-TAPIA S M,et al.Role of CD36 in cancer progression,stemness,and targeting[J].Front Cell Dev Biol,2022,10:1079076.
[6] 赵娜娜,王超,金惠新,等.合肥地区无偿献血人群CD36抗原缺失的调查[J].临床输血与检验,2021,23(2):152-155.
[7] 王田玮,郝佳瑶,马汉伟,等.CD36在常见消化系统恶性肿瘤转移中作用的研究进展[J].山东医药,2022,62(19):83-86.
[8] FENG W W,ZUPPE H T,KUROKAWA M.The role of CD36 in cancer progression and its value as a therapeutic target[J].Cells,2023,12(12):1605.
[9] TAI P P,WANG Z W,CHEN X Y,et al.Multi-omics analysis of the oncogenic value of copper Metabolism-Related protein COMMD2 in human cancers[J].Cancer Med,2023,12(10):11941-11959.
[10] LI Z X,ZHOU B,ZHU X S,et al.Differentiation-related genes in tumor-associated macrophages as potential prognostic biomarkers in non-small cell lung cancer[J].Front Immunol,2023,14:1123840.
[11] SHI T D,HU Z X,TIAN L,et al.Pan-cancer landscape of CENPO and its underlying mechanism in LUAD[J].Respir Res,2023,24(1):113.
[12] SZKLARCZYK D,KIRSCH R,KOUTROULI M,et al.The STRING database in 2023:protein-protein association networks and functional enrichment analyses for any sequenced genome of interest[J].Nucleic Acids Res,2023,51(D1):D638-D646.
[13] BOSCHINI C,ANDERSEN K K,SCHEIKE T H.Excess risk estimation for matched cohort survival data[J].Stat Methods Med Res,2019,28(10/11):3451-3465.
[14] LIU J F,LICHTENBERG T,HOADLEY K A,et al.An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics[J].Cell,2018,173(2):400-416.e11.
[15] 肿瘤医学论坛.2020年全球癌症最新数据解读[J].中国肿瘤临床与康复,2021,28(3):301.
[16] 黄彬亮,谢钊敏,王丹,等.广东潮汕地区恶性肿瘤与ABO血型的相关性分析[J].中国输血杂志,2023,36(3):254-257.
[17] LIAO X Z,YAN S,LI J L,et al.CD36 and its role in regulating the tumor microenvironment[J].Curr Oncol,2022,29(11):8133-8145.
[18] 中国抗癌协会肿瘤标志专业委员会遗传性肿瘤标志物协作组,中国抗癌协会肿瘤病理专业委员会分子病理协作组.肿瘤突变负荷检测及临床应用中国专家共识(2020年版)[J].中国癌症防治杂志,2020,12(5):485-494.
[19] GARG N,SINHA D,YADAV B,et al.ML-based texture and wavelet features extraction technique to predict gastric mesothelioma cancer[J].Biomed Res Int,2022,2022:1012684.
[20] JIN Z H,SANHUEZA C T,JOHNSON B,et al.Outcome of mismatch repair-deficient metastatic colorectal cancer:the mayo clinic experience[J].Oncologist,2018,23(9):1083-1091.
[21] ZHANG Z Y,LU M M,QIN Y,et al.Neoantigen:a new breakthrough in tumor immunotherapy[J].Front Immunol,2021,12:672356.
[22] 李岚,许斌,查莉.肿瘤纯度—肿瘤研究中一个被忽视的潜在混杂因素[J].肿瘤防治研究,2019,46(6):570-574.

血型CD36基因在泛癌中的综合分析

Comprehensive Analysis of Blood Group Gene CD36 in Pan Cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们